2jod

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 4: Line 4:
==Overview==
==Overview==
-
The pituitary adenylate cyclase-activating polypeptide (PACAP) receptor is, a class II G protein-coupled receptor that contributes to many different, cellular functions including neurotransmission, neuronal survival, and, synaptic plasticity. The solution structure of the potent antagonist PACAP, (residues 6'-38') complexed to the N-terminal extracellular (EC) domain of, the human splice variant hPAC1-R-short (hPAC1-R(S)) was determined by NMR., The PACAP peptide adopts a helical conformation when bound to hPAC1-R(S), with a bend at residue A18' and makes extensive hydrophobic and, electrostatic interactions along the exposed beta-sheet and, interconnecting loops of the N-terminal EC domain. Mutagenesis data on, both the peptide and the receptor delineate the critical interactions, between the C terminus of the peptide and the C terminus of the EC domain, that define the high affinity and specificity of hormone binding to, hPAC1-R(S). These results present a structural basis for hPAC1-R(S), selectivity for PACAP versus the vasoactive intestinal peptide and also, differentiate PACAP residues involved in binding to the N-terminal, extracellular domain versus other parts of the full-length hPAC1-R(S), receptor. The structural, mutational, and binding data are consistent with, a model for peptide binding in which the C terminus of the peptide hormone, interacts almost exclusively with the N-terminal EC domain, whereas the, central region makes contacts to both the N-terminal and other, extracellular parts of the receptor, ultimately positioning the N terminus, of the peptide to contact the transmembrane region and result in receptor, activation.
+
The pituitary adenylate cyclase-activating polypeptide (PACAP) receptor is a class II G protein-coupled receptor that contributes to many different cellular functions including neurotransmission, neuronal survival, and synaptic plasticity. The solution structure of the potent antagonist PACAP (residues 6'-38') complexed to the N-terminal extracellular (EC) domain of the human splice variant hPAC1-R-short (hPAC1-R(S)) was determined by NMR. The PACAP peptide adopts a helical conformation when bound to hPAC1-R(S) with a bend at residue A18' and makes extensive hydrophobic and electrostatic interactions along the exposed beta-sheet and interconnecting loops of the N-terminal EC domain. Mutagenesis data on both the peptide and the receptor delineate the critical interactions between the C terminus of the peptide and the C terminus of the EC domain that define the high affinity and specificity of hormone binding to hPAC1-R(S). These results present a structural basis for hPAC1-R(S) selectivity for PACAP versus the vasoactive intestinal peptide and also differentiate PACAP residues involved in binding to the N-terminal extracellular domain versus other parts of the full-length hPAC1-R(S) receptor. The structural, mutational, and binding data are consistent with a model for peptide binding in which the C terminus of the peptide hormone interacts almost exclusively with the N-terminal EC domain, whereas the central region makes contacts to both the N-terminal and other extracellular parts of the receptor, ultimately positioning the N terminus of the peptide to contact the transmembrane region and result in receptor activation.
==About this Structure==
==About this Structure==
Line 13: Line 13:
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Protein complex]]
[[Category: Protein complex]]
-
[[Category: Barrett, L.W.]]
+
[[Category: Barrett, L W.]]
-
[[Category: Davis-Taber, R.A.]]
+
[[Category: Davis-Taber, R A.]]
-
[[Category: Hajduk, P.J.]]
+
[[Category: Hajduk, P J.]]
-
[[Category: Lake, M.R.]]
+
[[Category: Lake, M R.]]
-
[[Category: Olejniczak, E.T.]]
+
[[Category: Olejniczak, E T.]]
[[Category: Pereda-lopez, A.]]
[[Category: Pereda-lopez, A.]]
-
[[Category: Richardson, P.L.]]
+
[[Category: Richardson, P L.]]
-
[[Category: Scott, V.E.]]
+
[[Category: Scott, V E.]]
-
[[Category: Solomon, L.R.]]
+
[[Category: Solomon, L R.]]
[[Category: Song, D.]]
[[Category: Song, D.]]
[[Category: Sun, C.]]
[[Category: Sun, C.]]
-
[[Category: Uchic, M.E.]]
+
[[Category: Uchic, M E.]]
-
[[Category: Walter, K.A.]]
+
[[Category: Walter, K A.]]
[[Category: protein/peptide complex]]
[[Category: protein/peptide complex]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 15:11:51 2008''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 18:04:40 2008''

Revision as of 16:04, 21 February 2008


2jod

Drag the structure with the mouse to rotate

Pac1-Rshort N-terminal EC domain Pacap(6-38) complex

Overview

The pituitary adenylate cyclase-activating polypeptide (PACAP) receptor is a class II G protein-coupled receptor that contributes to many different cellular functions including neurotransmission, neuronal survival, and synaptic plasticity. The solution structure of the potent antagonist PACAP (residues 6'-38') complexed to the N-terminal extracellular (EC) domain of the human splice variant hPAC1-R-short (hPAC1-R(S)) was determined by NMR. The PACAP peptide adopts a helical conformation when bound to hPAC1-R(S) with a bend at residue A18' and makes extensive hydrophobic and electrostatic interactions along the exposed beta-sheet and interconnecting loops of the N-terminal EC domain. Mutagenesis data on both the peptide and the receptor delineate the critical interactions between the C terminus of the peptide and the C terminus of the EC domain that define the high affinity and specificity of hormone binding to hPAC1-R(S). These results present a structural basis for hPAC1-R(S) selectivity for PACAP versus the vasoactive intestinal peptide and also differentiate PACAP residues involved in binding to the N-terminal extracellular domain versus other parts of the full-length hPAC1-R(S) receptor. The structural, mutational, and binding data are consistent with a model for peptide binding in which the C terminus of the peptide hormone interacts almost exclusively with the N-terminal EC domain, whereas the central region makes contacts to both the N-terminal and other extracellular parts of the receptor, ultimately positioning the N terminus of the peptide to contact the transmembrane region and result in receptor activation.

About this Structure

2JOD is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS., Sun C, Song D, Davis-Taber RA, Barrett LW, Scott VE, Richardson PL, Pereda-Lopez A, Uchic ME, Solomon LR, Lake MR, Walter KA, Hajduk PJ, Olejniczak ET, Proc Natl Acad Sci U S A. 2007 May 8;104(19):7875-80. Epub 2007 Apr 30. PMID:17470806

Page seeded by OCA on Thu Feb 21 18:04:40 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools